Spectrum working with Angus
Under a new agreement, Spectrum Chemicals is to distribute Angus Chemical’s TRIS Amino AC USP/EP (pictured) and BIS-TRIS biologics-grade buffers to the biopharmaceutical and life sciences industries in the US and Canada. The company said that these complement its own bioprocessing portfolio such as the BioCertified product line.
Angus is the world’s largest and only fully integrated manufacturer of TRIS buffers. These are used as buffering agents in cell culture and bioprocessing applications, and in the purification of biological molecules in downstream processing.
RELATED ARTICLES
Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.
Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China.
At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitional year in 2023.
At CPHI in Milan in October, eight Indian CDMOs announced that they have formed a trade group to raise the profile of India’s drug services sector and make it a destination of choice.
CatSci has opened a second oligonucleotides laboratory, which it will use “to introduce novel workflows for the rapid production of vast numbers of oligos at a scale optimised for rapid screening”.
Swedish-based CDMO Recipharm announced at CPHI that it is “expanding its pharmaceutical development capabilities through targeted investments and the integration of cutting-edge technologies”.
